hCG vs. Gonadorelin on TRT: Fertility, Testicular Function and Evidence

Physician-reviewed TRT education

hCG vs Gonadorelin on TRT

Both can affect the hypothalamic-pituitary-gonadal axis, but they work differently and should not be treated as interchangeable add-ons to testosterone therapy.

Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

How hCG and gonadorelin work differently

Why fertility changes the conversation

Exogenous testosterone can suppress LH and FSH through negative feedback at the hypothalamus and pituitary. That suppression can reduce intratesticular testosterone and sperm production. For men who want current or future fertility, the 2024 AUA/ASRM guideline advises against prescribing exogenous testosterone. Adding hCG or another medication does not establish a reliable fertility-preservation strategy.

Depending on the diagnosis, clinicians may consider hCG, selective estrogen receptor modulators, aromatase inhibitors, FSH-containing regimens, or combinations of these approaches. The correct choice depends on baseline LH and FSH, semen analysis, testicular function, fertility goals, prior testosterone exposure, and the underlying cause of low testosterone.

Read our detailed guide to TRT and male fertility and our overview of hCG therapy.

Does hCG have better evidence than gonadorelin for men on TRT?

For the specific question of preserving testicular stimulation while a man is receiving exogenous testosterone, hCG has a more established physiologic rationale and a larger body of clinical use. hCG directly stimulates the LH receptor even when pituitary LH has been suppressed by TRT.

Gonadorelin can stimulate LH and FSH when the pituitary is capable of responding, but GnRH physiology is highly pulse-dependent. Published studies showing restoration of spermatogenesis generally used pulsatile delivery every 60 to 120 minutes, commonly through a pump. Those data should not be assumed to prove that a few intermittent injections each week will produce the same effect.

This is why NovaGenix does not present hCG and gonadorelin as equivalent medications.

Can hCG help testicular size or intratesticular testosterone?

Testicular shrinkage during TRT is primarily related to suppression of gonadotropin signaling and reduced intratesticular testosterone. Because hCG stimulates the LH receptor directly, it can increase testicular testosterone production in appropriate patients. Whether this translates into preserved fertility depends on the individual and cannot be determined from testicular size alone.

A semen analysis is the clinically meaningful test when fertility matters. Symptoms such as reduced testicular volume or ejaculate volume may prompt evaluation, but they do not substitute for objective fertility testing.

Related reading: Will your testes shrink on testosterone?

Is hCG FDA-approved?

hCG has FDA-approved uses in male hypogonadotropic hypogonadism. Use alongside TRT for fertility preservation, maintenance of testicular function, or related goals may be off-label depending on the clinical situation. Off-label prescribing is a medical decision and is not the same as FDA approval for that specific use.

The AUA/ASRM guideline specifically notes that hCG is FDA-approved for use in men with hypogonadotropic hypogonadism and may be used in selected infertile men with low testosterone.

Is gonadorelin FDA-approved for this use?

Pulsatile GnRH therapy has a long history in the treatment of hypothalamic forms of hypogonadotropic hypogonadism, but the 2024 AUA/ASRM guideline states that pulsatile GnRH is not currently approved in the United States or Europe. Evidence supporting pulsatile therapy should therefore not be conflated with routine intermittent gonadorelin injections marketed as a simple substitute for hCG in men on TRT.

What about side effects?

Both therapies can have adverse effects and require monitoring. hCG can increase endogenous testosterone and estradiol, and may contribute to acne, breast tenderness, fluid retention, mood changes, or other androgen- and estrogen-related effects in susceptible patients. Gonadorelin can cause injection-site reactions and other adverse effects, and its effectiveness depends on an intact and responsive pituitary-gonadal axis.

No medication should be chosen simply because it is cheaper, easier to obtain, or marketed as a replacement for another drug.

What does NovaGenix generally consider?

For men already using TRT, the clinical question is not simply “hCG or gonadorelin?” The decision starts with the goal:

• Fertility now: semen analysis and a fertility-focused treatment plan are more important than symptoms alone.
• Future fertility: discuss reproductive goals before starting or while modifying TRT.
• Testicular atrophy or discomfort: evaluate symptoms, gonadotropin suppression, treatment history, and whether hCG is appropriate.
• Low testosterone without TRT: treatment depends on whether the cause is primary testicular failure, hypothalamic/pituitary dysfunction, medication-related suppression, obesity/metabolic disease, or another condition.

For patients interested in physician-led TRT, review our testosterone replacement therapy program and low-testosterone testing process.

Frequently asked questions

Is hCG better than gonadorelin for fertility on TRT?

hCG has a clearer role and stronger guideline support in male reproductive medicine. Gonadorelin can be effective when delivered as true pulsatile GnRH therapy in selected men with hypothalamic hypogonadism, but evidence for intermittent gonadorelin injections as a routine TRT adjunct is much weaker.

Can gonadorelin replace hCG?

Not automatically. The medications act at different levels of the hormonal axis and have different evidence bases. A substitution should not be made solely because one product is easier to obtain.

Can hCG preserve sperm production while on TRT?

hCG can support intratesticular testosterone and is used in fertility-preserving strategies, but it does not guarantee preserved sperm production. Men with fertility goals should consider semen analysis and individualized reproductive evaluation.

Can I take hCG and testosterone together?

They may be prescribed together in selected patients. The regimen should be based on fertility goals, symptoms, laboratory results, risks, and physician monitoring.

Should I stop TRT if I want fertility?

That depends on the urgency of fertility goals, semen parameters, duration of TRT, and the treatment plan. The 2024 AUA/ASRM guideline advises against prescribing exogenous testosterone to men interested in current or future fertility. Adding hCG or a SERM does not remove that concern; evidence for preserving fertility with such combinations is too limited to recommend this approach.

Medical sources

• AUA/ASRM Guideline: Diagnosis and Treatment of Infertility in Men, amended 2024
• Systematic review and meta-analysis: pulsatile GnRH versus gonadotropin therapy in congenital hypogonadotropic hypogonadism
• 2024 study of pulsatile GnRH therapy in male congenital hypogonadotropic hypogonadism
• Review: gonadotropin treatment for male hypogonadotropic hypogonadism

This article is educational and does not provide individualized medical advice. Treatment decisions require evaluation by a qualified healthcare professional.